These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 29753057

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
    Yélamos O, Navarrete-Dechent C, Marchetti MA, Rogers T, Apalla Z, Bahadoran P, Blázquez-Sánchez N, Busam K, Carrera C, Dusza SW, de la Fouchardière A, Ferrara G, Gerami P, Kittler H, Lallas A, Malvehy J, Millán-Cayetano JF, Nelson KC, Quan VL, Puig S, Stevens H, Thomas L, Marghoob AA.
    J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062
    [Abstract] [Full Text] [Related]

  • 3. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature.
    Wysozan TR, Khelifa S, Turchan K, Alomari AK.
    J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729
    [Abstract] [Full Text] [Related]

  • 4. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z, Buljan M, Busam KJ.
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [Abstract] [Full Text] [Related]

  • 5. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.
    Zhang AJ, Rush PS, Tsao H, Duncan LM.
    J Cutan Pathol; 2019 Dec; 46(12):965-972. PubMed ID: 31233225
    [Abstract] [Full Text] [Related]

  • 6. Novel insights into the BAP1-inactivated melanocytic tumor.
    Donati M, Martinek P, Steiner P, Grossmann P, Vanecek T, Kastnerova L, Kolm I, Baneckova M, Donati P, Kletskaya I, Kalmykova A, Feit J, Blasch P, Szilagyi D, Baldi A, Persichetti P, Crescenzi A, Michal M, Kazakov DV.
    Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909
    [Abstract] [Full Text] [Related]

  • 7. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
    Soares de Sá BC, de Macedo MP, Torrezan GT, Braga JCT, Fidalgo F, Moredo LF, Lellis R, Duprat JP, Carraro DM.
    BMC Cancer; 2019 Nov 09; 19(1):1077. PubMed ID: 31706282
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Germline mutations in BAP1 predispose to melanocytic tumors.
    Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rütten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR.
    Nat Genet; 2011 Aug 28; 43(10):1018-21. PubMed ID: 21874003
    [Abstract] [Full Text] [Related]

  • 10. Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study.
    Cabaret O, Perron E, Bressac-de Paillerets B, Soufir N, de la Fouchardière A.
    Genes Chromosomes Cancer; 2017 Sep 28; 56(9):691-694. PubMed ID: 28560743
    [Abstract] [Full Text] [Related]

  • 11. RAF1 Gene Fusions as a Possible Driver Mechanism in Rare BAP1-Inactivated Melanocytic Tumors: A Report of 2 Cases.
    Donati M, Martinek P, Kastnerova L, Persichetti P, Michal M, Kazakov DV.
    Am J Dermatopathol; 2020 Dec 28; 42(12):961-966. PubMed ID: 32769548
    [Abstract] [Full Text] [Related]

  • 12. BAP1-inactivated melanocytic tumors show prominent centrosome amplification and associated loss of primary cilia.
    Ye J, Sheahon KM, LeBoit PE, McCalmont TH, Lang UE.
    J Cutan Pathol; 2021 Nov 28; 48(11):1353-1360. PubMed ID: 34085298
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. BAP1-inactivated melanocytic tumor with preserved BAP1 expression? Morphology to the rescue!
    Duncan LM, Tetzlaff MT.
    J Cutan Pathol; 2020 May 28; 47(5):459-461. PubMed ID: 32096236
    [Abstract] [Full Text] [Related]

  • 15. A case of molecularly confirmed BAP1 inactivated melanocytic tumor with retention of immunohistochemical expression: A confounding factor.
    Linos K, Atkinson AE, Yan S, Tsongalis GJ, Lefferts JA.
    J Cutan Pathol; 2020 May 28; 47(5):485-489. PubMed ID: 31891422
    [Abstract] [Full Text] [Related]

  • 16. NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report.
    Blokx WA, Rabold K, Bovenschen HJ, Ligtenberg MJ, Mensenkamp AR, van Lijnschoten G, van Zelst-Stams WA, Groenen PJ.
    Virchows Arch; 2015 Jan 28; 466(1):117-21. PubMed ID: 25342144
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation.
    Gerami P, Yélamos O, Lee CY, Obregon R, Yazdan P, Sholl LM, Guitart GE, Njauw CN, Tsao H.
    JAMA Dermatol; 2015 Nov 28; 151(11):1235-9. PubMed ID: 26154183
    [Abstract] [Full Text] [Related]

  • 19. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A, Mihm MC, Hoang MP.
    Hum Pathol; 2015 Feb 28; 46(2):239-45. PubMed ID: 25479927
    [Abstract] [Full Text] [Related]

  • 20. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
    Donati M, Šteiner P, Kazakov DV.
    Am J Dermatopathol; 2023 Feb 01; 45(2):117-122. PubMed ID: 36669076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.